Cancers | Free Full-Text | The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
Cancers | Free Full-Text | Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Prognostic factors for operable biliary tract cancer: serum levels of | OTT
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma - FullText - GE - Portuguese Journal of Gastroenterology 2017, Vol. 24, No. 3 - Karger Publishers
PDF) CA 242, a new tumour marker for pancreatic cancer: A comparison with CA 19-9, CA 50 and CEA
Combinatorial Serum Markers for CCA Diagnosis | Download Scientific Diagram
Causative conditions of elevated CA 19-9 levels in the elevated CA 19-9... | Download Scientific Diagram
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology
Diagnostic Role of Serum CA 19-9 for Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis - ScienceDirect
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
![PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a96fc01f495907ea18214fdc7db7ffd9b210d72c/2-TableI-1.png "PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar")
PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar
CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma - FullText - GE - Portuguese Journal of Gastroenterology 2017, Vol. 24, No. 3 - Karger Publishers
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. - Abstract - Europe PMC
The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
CA 19-9 Antigen - an overview | ScienceDirect Topics
CA 19-9: handle with care
![PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c14d81ca234c0d592f2e72050604bd015d1da96f/3-Table3-1.png "PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar")